INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 175 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 50 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 50 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | -33.3% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -40.0% | 50 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $5,000 | +66.7% | 50 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $3,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | -40.0% | 50 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $5,000 | +25.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -33.3% | 50 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $6,000 | +50.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | +33.3% | 50 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $3,000 | +50.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | -66.7% | 50 | 0.0% | 0.00% | -66.7% |
| Q2 2017 | $6,000 | +20.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $5,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | -37.5% | 50 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $8,000 | +14.3% | 50 | 0.0% | 0.01% | +25.0% |
| Q2 2016 | $7,000 | +16.7% | 50 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $6,000 | -14.3% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $7,000 | -12.5% | 50 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $8,000 | -33.3% | 50 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $12,000 | -14.3% | 50 | 0.0% | 0.01% | -16.7% |
| Q1 2015 | $14,000 | -30.0% | 50 | -60.0% | 0.01% | -33.3% |
| Q4 2014 | $20,000 | -33.3% | 125 | 0.0% | 0.01% | -52.6% |
| Q3 2014 | $30,000 | -57.7% | 125 | -58.3% | 0.02% | -76.5% |
| Q2 2014 | $71,000 | – | 300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |